These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14652632)

  • 1. Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans.
    Maghzal GJ; Brennan SO; George PM
    Thromb Haemost; 2003 Dec; 90(6):1021-8. PubMed ID: 14652632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
    Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.
    Ajjan R; Lim BC; Standeven KF; Harrand R; Dolling S; Phoenix F; Greaves R; Abou-Saleh RH; Connell S; Smith DA; Weisel JW; Grant PJ; Ariëns RA
    Blood; 2008 Jan; 111(2):643-50. PubMed ID: 17925485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.
    Lewandowski K; Kwaśnikowski P; Elikowski W; Zawilska K
    Kardiol Pol; 2003 Sep; 59(9):205-12. PubMed ID: 14618197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece.
    Rallidis LS; Gialeraki A; Fountoulaki K; Politou M; Sourides V; Travlou A; Lekakis I; Kremastinos DT
    Thromb Res; 2010 Jan; 125(1):34-7. PubMed ID: 19409601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.
    Lim BC; Ariëns RA; Carter AM; Weisel JW; Grant PJ
    Lancet; 2003 Apr; 361(9367):1424-31. PubMed ID: 12727396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
    Becatti M; Marcucci R; Bruschi G; Taddei N; Bani D; Gori AM; Giusti B; Gensini GF; Abbate R; Fiorillo C
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1355-61. PubMed ID: 24790138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation gene polymorphisms as risk factors for myocardial infarction in young Indian Asians.
    Pegoraro RJ; Ranjith N; Rom L
    Cardiovasc J S Afr; 2005; 16(3):152-7. PubMed ID: 16049588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
    Mannila MN; Silveira A; Hawe E; Eriksson P; Aillaud MF; Juhan-Vague I; Yudkin J; Margaglione M; di Minno G; Mussoni L; Tremoli E; Humphries S; Hamsten A;
    Thromb Haemost; 2004 Dec; 92(6):1240-9. PubMed ID: 15583729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.
    Collet JP; Nagaswami C; Farrell DH; Montalescot G; Weisel JW
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):382-6. PubMed ID: 14656741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
    He S; Bark N; Wang H; Svensson J; Blombäck M
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women.
    Leander K; Wiman B; Hallqvist J; Falk G; De Faire U
    J Intern Med; 2002 Oct; 252(4):332-41. PubMed ID: 12366606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship of beta-fibrinogen gene polymorphisms and ischaemic cardiocerebral vascular disease].
    Liu R; Li J; Mu H; Jiang Y; Wang Y; Dang Q; Cui X; Ji M; Huang F
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):453-6. PubMed ID: 12482353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.